Literature DB >> 10980627

Deletions at 11q23 in different lymphoma subtypes.

Y Zhu1, O Monni, K Franssila, E Elonen, J Vilpo, H Joensuu, S Knuutila.   

Abstract

BACKGROUND AND OBJECTIVES: Chromosome band 11q23 is frequently deleted in various types of neoplasm. The region represented by yeast artificial chromosome (YAC) clone 755b11 at 11q23 has been shown to be the minimal common region of deletion in mantle cell lymphoma (MCL) and B-cell chronic lymphocytic leukemia (B-CLL). The aim of the study was to determine the frequencies of 11q23 deletion in different lymphoma subtypes. DESIGN AND METHODS: We performed fluorescence in situ hybridization (FISH) analysis with YAC755b11 on either peripheral blood or lymph node biopsy (LN) specimens of patients diagnosed as having MCL (47), CLL/small lymphocytic lymphoma (SLL) (62), diffuse large cell lymphoma (DLCL) (17), follicular lymphoma (FL) (9), and Hodgkin's disease (HD) (11). Fifteen cases of reactive or normal lymph node biopsies were studied as controls.
RESULTS: Forty of the 161 (25%) samples exhibited deletions in the region represented by YAC755b11. The 11q23 deletion was found only in MCL (23, 49%), CLL / SLL (13, 21%) and DLCL (4, 24%). Three cases were classified as Richter's syndrome and they all exhibited the deletion at 11q23. The deletion frequencies in the blood specimens of typical CLL (30%) and lymph node specimens of CLL/SLL (13%) were remarkably different. INTERPRETATION AND
CONCLUSIONS: Our study demonstrated that the 11q23 deletion is not common in lymphomas other than MCL, CLL and DLCL. It also showed the possible correlation of the 11q23 deletion with the transformation of localized lymphoma to CLL, and with the development of Richter's syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 10980627

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  4 in total

1.  ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.

Authors:  Karen S Hathcock; Hesed M Padilla-Nash; Jordi Camps; Dong-Mi Shin; Daniel Triner; Arthur L Shaffer; Robert W Maul; Seth M Steinberg; Patricia J Gearhart; Louis M Staudt; Herbert C Morse; Thomas Ried; Richard J Hodes
Journal:  Blood       Date:  2015-09-23       Impact factor: 22.113

Review 2.  Recent advances in the diagnosis and therapy of Richter's syndrome.

Authors:  Ronan Swords; John Bruzzi; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

3.  Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?

Authors:  Fazila Asmar; Christoffer Hother; Gorjan Kulosman; Marianne Bach Treppendahl; Helene Myrtue Nielsen; Ulrik Ralfkiaer; Anja Pedersen; Michael Boe Møller; Elisabeth Ralfkiaer; Peter de Nully Brown; Kirsten Grønbæk
Journal:  Oncotarget       Date:  2014-04-15

4.  Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma.

Authors:  C Pommerenke; V Hauer; M Zaborski; R A F MacLeod; S Nagel; R M Amini; M Berglund; R Geffers; H G Drexler; H Quentmeier
Journal:  Blood Cancer J       Date:  2016-06-10       Impact factor: 11.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.